Biopharma × Business | ShaoChi Cheng

Helping biopharma turn good technology into good business

I've worked in oncology research, an H7N9 vaccine program, CDMO business development and international licensing of generics. Here I share practical perspectives on biopharma BD, market assessment, CDMO operations, and commercializing new technologies.

    ShaoChi Cheng
    ShaoChi ChengFounder of Chivanta
    • PM, NHRI H7N9 emergency pandemic vaccine program
    • BD for biologics, generics & CDMO
    • International licensing & market development strategy
    About the author →

    New here? Start with these three

    Pick the one closest to your question

    See full reading paths →

    Four topic series

    Organized in reading order, not just by date

    All series →

    Flagship

    CAR-T Commercialization Map

    From scientific breakthrough to disease treatment. How manufacturing, hospitals, and payment together shape the business of cell therapy.

      Latest articles

      See all →

      CHIVANTA NEWSLETTER

      How does good technology become good business?

      Subscribe to the Chivanta newsletter for practical perspectives on biopharma BD, product market assessment, CDMO operations and cost, and commercializing new technologies.

      Sent. Check your inbox to confirm.

      Something went wrong. Check your email and try again.

      Free · Unsubscribe anytime

      Iterations

      Beyond work: notes on choices, time, and creating.

      More notes →